Global IPO activity is accelerating into the fall, with major prospective listings spanning the U.S., Europe, Asia-Pacific and MENA. Altera leads the pipeline with a potential $2 billion-plus U.S. IPO, while Holtec Nuclear, Stratolaunch and Orion180 advance offerings. Europe features Belron and Ignis, while Asia-Pacific activity includes AirTrunk, Mynt, Musinsa and Transwarp Technology. In MENA, MNT-Halan has begun the Cairo listing process, highlighting broad investor appetite across technology, infrastructure, defense, insurance and fintech as issuance momentum builds toward year-end globally.

IPOX® Associate Lukas Muehlbauer commented on the fall IPO market as Holtec Nuclear targets a valuation of up to $10.2 billion in its U.S. IPO. He said early deals could set the tone for the broader market, with strong debuts potentially encouraging more listings and weak pricing or aftermarket performance narrowing the window. Muehlbauer added that economic fundamentals, market conditions and the Federal Reserve’s September meeting are likely to drive IPO activity, with limited impact from midterm elections this year.

U.S. IPO activity is led by SB Energy’s planned $5 billion Nasdaq deal, alongside Cumberland Farms’ pre-IPO financing and Golden Pet Brands’ New York plans. In Europe, Nscale is raising $3.5 billion ahead of a potential flotation, while Blackstone prepares Hotel Investment Partners for a Spanish listing. Asia-Pacific remains especially active, with Moonshot AI, Asia OneHealthcare, Ligent, Club Med, Akulaku, Jollibee’s international unit and VinFast-linked GSM all advancing toward Hong Kong or Malaysian IPOs across technology, healthcare, hospitality and mobility.

Reuters reports on SoftBank-backed SB Energy’s U.S. IPO filing as AI infrastructure investment accelerates. IPOX® Research Associate Lukas Muehlbauer comments on the company’s roughly $439 billion backlog, execution risks, and reliance on long-term customer commitments. He notes that investors must assess whether contracted demand can translate into future cash flow, while also weighing the uncertainty surrounding 20-year OpenAI leases in a rapidly evolving AI market and the sustainability of current infrastructure spending trends over the coming years.

This week’s IPOX Update highlights several major new listings across the U.S., Europe and Asia-Pacific. Oura is targeting a U.S. IPO of up to $3 billion, while Aggreko has filed for an NYSE listing that could raise about $1 billion. Ursa Major is pursuing a $2.3 billion SPAC transaction, and KNDS is considering reviving its European IPO. In Hong Kong, Syngenta remains a potential $10 billion candidate, while Medcaptain has launched its own offering ahead of a September market debut.

IPOX® Associate Lukas Muehlbauer was featured in Bloomberg’s Mideast Money newsletter, providing context on Abu Dhabi’s recent moves to take strategic companies private. He highlighted how similar transactions in other markets have often reflected governments’ desire for greater control over important assets, whether to support long-term investment or restructuring. His comments helped frame the AD Ports and TAQA developments within a broader global pattern of state-led ownership consolidation and strategic market repositioning across public equity markets worldwide today and beyond.

IPO activity accelerated across major markets, led by potentially record-sized U.S. offerings. Anthropic is preparing a public filing, while SB Energy targets at least $5 billion and General Atlantic revived listing plans. In Europe, Quantexa is weighing a London or U.S. IPO. Asia-Pacific activity includes a $1 billion Singapore data-center REIT and several Hong Kong technology listings. In Africa, Dangote Refinery advanced plans for a potential $5 billion Nigerian IPO after securing a $1 billion underwriting programme from its advisers.

German financial magazine FOCUS MONEY examines Oura’s planned IPO as the wearable technology company builds on strong growth and an expanding digital health platform. IPOX® Associate Lukas Muehlbauer comments on Oura’s positioning ahead of a potential listing, noting its evolution from a young wearable company into an established platform. He also highlights Oura’s focused product strategy versus larger technology groups, as the company targets further growth in the expanding global wearables market and recurring subscription-based customer revenue opportunities.

IPOX­® CEO Josef Schuster commented on Lyntris’ New York debut after shares fell 11.4%, valuing the defense contractor at $1.78 billion. Schuster said the market was discounting the company’s capital structure rather than treating it like a venture capital deal. He also noted that higher U.S. bond yields were pushing investors away from riskier, less-seasoned companies, including recent IPOs, even as earnings remained strong. Lyntris priced its IPO below its marketed range and reduced the offering size to 17 million shares, raising $297.5 million.

Global IPO activity is building across data centers, AI, semiconductors, robotics and consumer businesses. In the U.S., Vantage Data Centers is exploring a potential $10 billion IPO, while DayOne has confidentially filed for a $5 billion offering and Anthropic is meeting investors. Across Asia-Pacific, Moore Threads targets a major Hong Kong listing, alongside Vitalink, Mech-Mind and Kiwimoore. Malaysia’s ZUS Coffee and Japan’s Oliver are also advancing IPO plans, highlighting broader momentum across regional equity markets in 2026.

Reuters reports that Londian Wason’s NYSE debut valued the Chinese copper foil maker at about $2.01 billion, marking the largest U.S. IPO by a Chinese company in more than a year. IPOX® Research Associate Lukas Muehlbauer cautioned that the strong first-day performance, supported by a very low float and potential scarcity premium, should not be viewed as proof of a broader reopening for larger Chinese IPOs. He also highlighted potential future supply risks and customer concentration concerns for longer-term investors.

Global IPO activity is building across major markets, led by large planned offerings from Dangote Refinery, Moonshot AI, Nscale and Airtel Money. U.S. listings include Robinhood Ventures Fund II and Londian Wason, while Europe may see major transactions from KNDS and Kazakhstan’s KTZ. Hong Kong remains active with Moonshot AI and Sichuan Biokin, while Qatar’s Dandy advances its offering. Overall, the pipeline highlights strong investor interest in AI, infrastructure, financial services, industrials, biotechnology and energy-related issuers worldwide.

IPOX® Associate Muehlbauer was quoted in Reuters on Londian Wason’s planned U.S. IPO, which targets a valuation of up to $1.7 billion and could become the largest New York listing by a Chinese company in more than a year. He said the relatively small offering would be encouraging rather than signal a definitive market reopening, while highlighting stronger growth, profitability, battery demand, and investor concerns over the company’s reliance on a limited number of major customers for future growth prospects.